Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT03001622 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

BIOLOGICAL: IFX-1

Sponsor

InflaRx GmbH